JCO Precision Oncology

Lippincott Williams & Wilkins

Evaluation status available after sign-in

About the journal

JCO Precision Oncology is a journal published by Lippincott Williams & Wilkins in United States. It is listed in MEDLINE according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Lippincott Williams & Wilkins
ISSN
2473-4284
Country
United States
Access
Not open access / not declared

Index listings

  • MEDLINE · 2021-01-01
Indexing
MEDLINE
APC
—
Declared review time (DOAJ)
—
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

2034

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

74

i10-index

783

From OpenAlex open data (CC0).

Editorial & policy5
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
96%
ORCID iDs in current deposits
96%
Enrolled in Crossref Similarity Check
✓
Identity & continuity3
Alternate titles
JCO POJCO Precis OncolJournal of clinical oncology, precision oncology
Source type
journal
NLM unique ID (PubMed)
101705370
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Lung Cancer Treatments and Mutations
  • BRCA gene mutations in cancer
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Treatments and Mutations
  • Cancer Immunotherapy and Biomarkers
Show all subjects (75)
  • Genetic factors in colorectal cancer
  • Genetic factors in colorectal cancer
  • Genetic factors in colorectal cancer
  • Breast Cancer Treatment Studies
  • BRCA gene mutations in cancer
  • BRCA gene mutations in cancer
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Research Studies
  • Lung Cancer Research Studies
  • Colorectal Cancer Treatments and Studies
  • Colorectal Cancer Treatments and Studies
  • Colorectal Cancer Treatments and Studies
  • PARP inhibition in cancer therapy
  • PARP inhibition in cancer therapy
  • Genomics and Rare Diseases
  • HER2/EGFR in Cancer Research
  • Prostate Cancer Treatment and Research
  • Prostate Cancer Treatment and Research
  • PARP inhibition in cancer therapy
  • Prostate Cancer Treatment and Research
  • Sarcoma Diagnosis and Treatment
  • Pancreatic and Hepatic Oncology Research
  • Pancreatic and Hepatic Oncology Research
  • HER2/EGFR in Cancer Research
  • HER2/EGFR in Cancer Research
  • Lung Cancer Diagnosis and Treatment
  • Genomics and Rare Diseases
  • Genomics and Rare Diseases
  • Chromatin Remodeling and Cancer
  • Melanoma and MAPK Pathways
  • Melanoma and MAPK Pathways
  • Cancer Cells and Metastasis
  • Pancreatic and Hepatic Oncology Research
  • Cancer Cells and Metastasis
  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Diagnosis and Treatment
  • Sarcoma Diagnosis and Treatment
  • Breast Cancer Treatment Studies
  • Sarcoma Diagnosis and Treatment
  • Melanoma and MAPK Pathways
  • Breast Cancer Treatment Studies
  • Neuroblastoma Research and Treatments
  • Neuroblastoma Research and Treatments
  • Prostate Cancer Diagnosis and Treatment
  • DNA Repair Mechanisms
  • DNA Repair Mechanisms
  • Glioma Diagnosis and Treatment
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Advanced Breast Cancer Therapies
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Advanced Breast Cancer Therapies
  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Diagnosis and Treatment
  • Statistical Methods in Clinical Trials
  • Statistical Methods in Clinical Trials
  • Gastric Cancer Management and Outcomes
  • Glioma Diagnosis and Treatment
  • Glioma Diagnosis and Treatment
  • Neuroendocrine Tumor Research Advances
  • Neuroendocrine Tumor Research Advances
  • Advanced Breast Cancer Therapies
  • Acute Myeloid Leukemia Research
  • Ovarian cancer diagnosis and treatment
  • Lung Cancer Research Studies
  • Statistical Methods in Clinical Trials
  • Cholangiocarcinoma and Gallbladder Cancer Studies

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: